[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335599-105":59,"doc-detail-335599-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","rna-binding-protein-hur-inhibition-induces-multiple-programmed-cell-death-in-breast-and-prostate-cancer","RNA-binding protein HuR inhibition induces multiple programmed cell death in breast and prostate cancer","","The RNA-binding protein Hu antigen R (HuR) is central to cancer progression, and prior studies link it to suppression of cell death, yet the mechanisms of death triggered by HuR inhibition were unclear. Using the small-molecule inhibitor KH-3, researchers assessed proliferation, colony formation, and cell death in multiple cancer cell lines, focusing on breast and prostate models. KH-3 induced apoptotic death, autophagy-associated cell death, and ferroptosis, partially rescued by autophagy and ferroptosis inhibitors, and validated in mouse xenografts. KH-3 decreased HuR target expression and modulated cFLIP, SLC7A11, XIAP, and Survivin, promoting caspase activation and PARP cleavage.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/rna-binding-protein-hur-inhibition-induces-multiple-programmed-cell-death-in-breast-and-prostate-cancer/335599/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/rna-binding-protein-hur-inhibition-induces-multiple-programmed-cell-death-in-breast-and-prostate-cancer/335599.png","ImageObject",300,407,{"name":92,"@type":93},"Evangeline","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main finding about HuR inhibition in breast and prostate cancer?","Question",{"text":112,"@type":113},"HuR inhibition by the small-molecule inhibitor KH-3 triggers multiple programmed cell death modalities, including apoptosis, autophagy-associated cell death, and ferroptosis, in cancer cells from breast and prostate contexts.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did the study evaluate the effects of HuR inhibition?",{"text":117,"@type":113},"The researchers assessed cell proliferation and colony formation, measured different forms of cell death across multiple cancer cell lines, and further validated anti-tumor effects using mouse xenograft models.",{"name":119,"@type":110,"acceptedAnswer":120},"Which molecular targets were affected by KH-3, and what was the downstream outcome?",{"text":121,"@type":113},"KH-3 reduced HuR target expression involved in apoptosis and ferroptosis suppression, including cFLIP and SLC7A11, and also decreased XIAP and Survivin, which enhanced caspase activation and PARP cleavage, leading to apoptosis.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},335599,1790171195,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},13056703019662,"https://ap-avatar.wpscdn.com/avatar/be000253a8e92610077?_k=1778726343310543188","Wei et al. Cell Communication and Signaling (2024) 22:580  \n[https://doi.org/10.1186/s12964-024-01916-z](https://doi.org/10.1186/s12964-024-01916-z)  \nCell Communication and Signaling  \n RESEARCH Open Access  \nRNA-binding protein HuR inhibition induces multiple programmed cell death in breast and prostate cancer  \nLanjing Wei1,2, Sung Hae Kim3, Ahlam M. Armaly4, Jeffrey Aubé4, Liang Xu3,5,6* and Xiaoqing Wu3,5*  \nAbstract  \nThe RNA-binding protein Hu antigen R (HuR) plays a pivotal role in cancer progression, and previous studies have demonstrated its involvement in suppressing cell death in cancer. However, the precise mechanisms underlying HuR inhibition-induced cell death remain elusive. Here, we investigated the impacts of HuR functional inhibition via the small molecule inhibitor KH-3 on cell proliferation, colony formation, and cell death across multiple cancer cell lines, with an emphasis on breast and prostate cancers. KH-3 treatment induced apoptotic cell death of various cancer cell lines, as well as autophagy-associated cell death and ferroptosis. Remarkably, KH-3-induced cell death was partially rescued by an autophagy inhibitor and a ferroptosis inhibitor. The anti-tumor effects of KH-3 were further validated in two mouse xenograft models of human prostate cancer. Mechanistically, KH-3 reduced the expression of HuR targets involved in apoptosis and ferroptosis suppression, including cFLIP and SLC7A11, respectively. Moreover, cFLIP silencing enhanced Caspase-8 activation as well as PARP cleavage in both breast cancer and prostate cancer cells. Both KH-3-induced pharmacological HuR inhibition and RNA interference-mediated HuR knockdown reduced the expression of SLC7A11 . Additionally, KH-3 also reduced XIAP and Survivin, enhancing the activation of multiple caspases and leading to apoptosis. This study highlights the critical roles of HuR in programmed cell death regulation, advocating HuR inhibition as a promising anti-tumor strategy for cell-death-inducing cancer therapy.  \nKeywords HuR, Cell death, Breast cancer, Prostate cancer, Mouse tumor models  \n*Correspondence: Liang Xu [xul@ku.edu](xul@ku.edu)[ ](xul@ku.edu)Xiaoqing Wu [wuxq@ku.edu](wuxq@ku.edu)  \n1 Bioengineering Program, The University of Kansas, Lawrence, KS 66045-7534, USA  \n2 Present Address: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA  \n3 Department of Molecular Biosciences, The University of Kansas, Lawrence, KS 66045-7534, USA  \n4 Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, The University of North Carolina, Chapel Hill, NC 27599, USA  \n5 The University of Kansas Cancer Center, The University of Kansas Medical Center, Kansas City, KS 66160, USA  \n6 Department of Radiation Oncology, The University of Kansas Medical Center, Kansas City, KS 66160, USA  \nBackground  \nThe RNA-binding protein Hu antigen R (HuR), also known as ELAVL1 (embryonic lethal, abnormal vision, Drosophila-like protein 1), is a well-characterized human RNA binding protein associated with breast cancer [1]. HuR binds to the U-and AU-rich elements (AREs), predominantly located in the 3’-untranslated region (UTR) and occasionally in the 5’-UTR of target mRNAs [2]. Through binding to target mRNAs using three RNArecognition-motifs (RRMs) [3, 4], HuR post-transcriptionally regulates the mRNAs, leading to various effects such as mRNA stabilization, upregulation of translation, and inhibition of translation of certain target mRNAs [2]. By interacting with target mRNAs, HuR promotes the  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed mater","cbCaiogYbVWOUx16","https://ap.wps.com/l/cbCaiogYbVWOUx16","pdf",7207757,14,"English","# Abstract\n## Background\n## HuR roles in regulating cell death\n## Cell death types and mechanisms","[{\"question\":\"What is the main finding about HuR inhibition in breast and prostate cancer?\",\"answer\":\"HuR inhibition by the small-molecule inhibitor KH-3 triggers multiple programmed cell death modalities, including apoptosis, autophagy-associated cell death, and ferroptosis, in cancer cells from breast and prostate contexts.\"},{\"question\":\"How did the study evaluate the effects of HuR inhibition?\",\"answer\":\"The researchers assessed cell proliferation and colony formation, measured different forms of cell death across multiple cancer cell lines, and further validated anti-tumor effects using mouse xenograft models.\"},{\"question\":\"Which molecular targets were affected by KH-3, and what was the downstream outcome?\",\"answer\":\"KH-3 reduced HuR target expression involved in apoptosis and ferroptosis suppression, including cFLIP and SLC7A11, and also decreased XIAP and Survivin, which enhanced caspase activation and PARP cleavage, leading to apoptosis.\"}]","RNA-binding protein HuR inhibition induces multiple programmed cell death in breast and prostate cancer | PDF",1790011573,35]